Clinical Trials Directory

Trials / Unknown

UnknownNCT05855876

Reversal of Battle-Related Aging (ROBRA) in a Special Operations Forces Cohort

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Stella Center · Academic / Other
Sex
All
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine measures of GrimAge clock in SOF members undergoing treatment for PTSD/TBI using CSB.

Detailed description

The primary objective of this study is to assess the impact of a combined protocol of subanesthetic ketamine infusions (SKI) and bilateral cervical sympathetic blocks (CSB) on aging, as measured by the GrimAge epigenetic clock. The secondary objective of this study is to assess the impact of this treatment paradigm on PTSD and mental health, as measured over a 6 month time period using the following questionnaires: Post-traumatic Stress Disorder Checklist (PCL-5), Patient Health Questionnaire 9 (PHQ-9), Depressive Symptom Index-Suicidality Subscale (DSI-SS), Generalized Anxiety Disorder 7-item (GAD-7), and Neurobehavioral Symptom Inventory (NSI). The tertiary objectives of the study are to investigate if PTSD is associated with significantly reduced free testosterone levels and increased C-reactive protein (CRP) levels.

Conditions

Interventions

TypeNameDescription
PROCEDUREsubanesthetic ketamine infusions and bilateral cervical sympathetic blocksCombined protocol of subanesthetic ketamine infusions and bilateral cervical sympathetic blocks

Timeline

Start date
2023-07-05
Primary completion
2024-04-05
Completion
2024-04-05
First posted
2023-05-12
Last updated
2023-07-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05855876. Inclusion in this directory is not an endorsement.